Disclaimer: Set-up shown here is only for educational purpose only; This is not a sell or buy recommendation. We are not responsible for any gain or loss; Consult your financial advisor before your execution of any recommended trade.
There are heavy chance that most of the presented scripts does not meet set (described) entry conditions, as most of the posted...
Disclaimer: Set-up shown here is only for educational purpose only; This is not a sell or buy recommendation. We are not responsible for any loss or gain; Consult your financial advisor before your execution of any recommended trade.
There are heavy chance that most of the presented scripts does not meet set (described) entry conditions, as most of the posted...
Aurobindo Pharma Limited is a pharmaceutical company. The Company is engaged in producing oral and injectable generic formulations and active pharmaceutical ingredients (APIs). Its product portfolio is spread over seven therapeutic/product areas, including antibiotics, anti-retrovirals, cardiovascular, central nervous system, gastroenterologicals, anti-allergies and anti-diabetics. It is engaged in developing a range of oncology and hormonal products. It is also developing inhalation and dermatology products, such as pressurized metered-dose inhaler (pMDI). It markets its products through chain stores in the United States. It has developed over three injectable penem products. The Company, through its subsidiary, manufactures and sells nutritional supplements. It has over 10 manufacturing units and approximately two research and development centers. The Company, in addition to marketing its products domestically, also markets its products globally in over 150 countries.
This website uses cookies to ensure you get the best experience on our website. To learn more about cookies, including how to control cookies, please read our Cookies Policy.
AUROPHARMA
